Author:
He Yingxia,Wang Jie,Yao Fang,Lu Pan,Xie Yafang,Li Xiuwen,Liu Qiangwei,Liu Yang,Cao Dan,Liang Jun,Tian Dan,Liu Guan
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27733282.
2. Korte SM, Prins J, Krajnc AM, et al. The many different faces of major depression: it is time for personalized medicine. Eur J Pharmacol. 2015;753:88–104. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25592320.
3. Effexor XR (venlafaxine hydrochloride) extended-release capsules [package insert].
4. Troy SM, Dilea C, Martin PT, et al. Pharmacokinetics of once-daily venlafaxine extended release in healthy volunteers. Current Therapeutic Research. 1997;58(8):504–14. Available from: https://www.sciencedirect.com/science/article/pii/S0011393X97800422.
5. Troy SM, Parker VP, Hicks DR, et al. Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine. J Clin Pharmacol. 1997;37(10):954–61. Available from: https://www.ncbi.nlm.nih.gov/pubmed/9505987.